Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide Implant Long-Term Safety in Acromegaly
NCT01295060Phase 3Terminated
- Sponsor
- Endo International plc
- Start
- Feb 2011
- Primary completion
- Apr 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of octreotide in acromegaly, sponsored by Endo International plc. Started Feb 2011; status: terminated.
02
Drugs
octreotide
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT01295060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01295060.